Multi-center prospective randomized control trial of Biolimus Eluting Stent System(TRE-956)

Authors
Category Primary study
JournalUMIN Clinical Trials Registry
Year 2007
INTERVENTION: Implantation of TRE‐956 Implantation of Cypher CONDITION: ischemic heart disease PRIMARY OUTCOME: TVF at 9M INCLUSION CRITERIA: Patient is eligible for PCI or CABG. The target lesion is a single de novo coronary artery lesion one or 2 vessels. The target lesion length must be <= 30 mm (visual estimate). The target reference vessel diameter must be >= 2.5mm and <= 3.5mm (visual estimate).
Epistemonikos ID: 74f7304c49a29bbe1937ba1e0f160fc594c6bacb
First added on: Aug 21, 2024